- cafead Feb 04, 2021 at 11:12: AM
via GlaxoSmithKline plc GSK reported fourth-quarter 2020 adjusted earnings of 62 cents per American depositary share (“ADS”), which missed the Zacks Consensus Estimate of 70 cents. Moreover, adjusted earnings were down 6% year over year on a reported basis and 5% at constant exchange rate (“CER”) due to higher research and development expenses.
article source
article source